Purdue Researchers Test Previously Approved FDA Drugs to Treat Lowe Syndrome
February 29, 2024
February 29, 2024
WEST LAFAYETTE, Indiana, Feb. 29 (TNSres) -- Purdue University issued the following news release:
* * *
Early tests show promise in repurposing rapamycin and statins for the rare genetic disorder that affects the eyes, kidneys and nervous system
* * *
Purdue University researchers have developed a patented therapeutic strategy for Lowe syndrome, an incurable and rare genetic disorder, by repurposing two drugs previously approved by the U.S. Foo . . .
* * *
Early tests show promise in repurposing rapamycin and statins for the rare genetic disorder that affects the eyes, kidneys and nervous system
* * *
Purdue University researchers have developed a patented therapeutic strategy for Lowe syndrome, an incurable and rare genetic disorder, by repurposing two drugs previously approved by the U.S. Foo . . .